Free tool
Diagnostics stocks
We cover 9 companies grouped under the Diagnostics theme. The median market value in the group is $331.49M. Across the group, the median move over the past trading day is +0.07%. Price change over the past year runs from −37.5% to +31.0% across the middle 80 percent of the group, with a median of −13.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CSTL | Castle Biosciences, Inc. | $1.02B | Small cap | +70.15% |
| IDX.AX | Integral Diagnostics Limited | $638.89M | Small cap | −17.78% |
| CEVI.ST | CellaVision AB (publ) | $413.78M | Small cap | −3.32% |
| ACL.AX | Australian Clinical Labs Limited | $386.24M | Small cap | +12.06% |
| YDES | YD Bio Ltd | $331.49M | Small cap | −64.97% |
| 0RAR.L | Stratec SE | $275.63M | Small cap | −13.37% |
| XGN | Exagen Inc. | $184.11M | Small cap | −22.84% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $179.10M | Small cap | +21.25% |
| BVXP.L | Bioventix PLC | $124.78M | Small cap | −30.64% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.